Region Skane

Address
Dockplatsen 26, Malmo S:t Petri

Sponsor Overview

assignment
35
sponsored trials
science
71
molecules
location_city
113
research centres
public
10
countries
person_search
246
investigators

Specializations

Oncology and Haematological Malignancies

Research activity includes treatment strategies for non-small cell lung cancer, triple-negative breast cancer, dedifferentiated liposarcoma, mantle cell lymphoma, diffuse large B-cell lymphoma, gastrointestinal stromal tumor, and neuroendocrine tumours. Additional interest is seen in papillary craniopharyngioma and resectable gastric and gastroesophageal junction adenocarcinoma.

  • Solid tumours
  • Lymphoma
  • Targeted cancer therapy
  • Perioperative oncology

Its oncology portfolio spans both tumour-directed therapy and disease-specific management across adult and selected rare cancers.

Neurology and Neurodegenerative Disorders

Clinical research covers Parkinson's disease, Alzheimer's disease, frontotemporal dementia, progressive supranuclear palsy, corticobasal degeneration, mild cognitive impairment, traumatic brain injury, subarachnoid hemorrhage, intracerebral hemorrhage, and cerebral commotio.

  • Movement disorders
  • Dementia and cognitive decline
  • Brain injury
  • Neuroimaging

There is also interest in tau-related pathology and diagnostic approaches for early neurodegenerative change.

Gastroenterology, Hepatology, and Inflammatory Bowel Disease

Studies address non-alcoholic fatty liver disease, liver tumours, Crohn's disease, and ulcerative colitis, alongside surgical and medical management of gastrointestinal conditions. The portfolio also includes complement-mediated renal disease such as C3 glomerulopathy.

  • Liver disease
  • Inflammatory bowel disease
  • Renal complement disorders
  • Gastrointestinal surgery

Research spans chronic inflammatory disease, metabolic liver disease, and selected hepatobiliary and renal complications.

Cardiovascular, Vascular, and Infectious Diseases

Active areas include abdominal aortic aneurysm, chronic coronary syndrome, infectious endocarditis, Staphylococcus aureus bacteraemia, and urinary tract infection caused by resistant bacteria. The research portfolio also extends to atherosclerotic and vascular intervention topics.

  • Vascular surgery
  • Coronary disease
  • Bacterial bloodstream infection
  • Antimicrobial resistance

These studies reflect interest in both procedural outcomes and infection management in complex cardiovascular and surgical settings.

Endocrine, Metabolic, and Mental Health Conditions

Research includes Graves' ophthalmopathy, Graves' disease, depression, major depressive disorder, anorexia nervosa, iron deficiency in adolescent girls, and obesity with metabolic liver involvement. The sponsor also funds work in inflammatory rheumatic disease and treatment-related immune responses.

  • Thyroid eye disease
  • Depressive disorders
  • Eating disorders
  • Metabolic and nutritional disorders

Its therapeutic interests cover psychiatric care, endocrine autoimmunity, and nutritional deficiency across adolescent and adult populations.

Sponsored Trials

Trial Name Country Status
A Randomized Phase III Study of Adjuvant Imatinib for Recurrence-Free Survival in High-Risk Operable Gastrointestinal Stromal Tumor PatientsAustria AustriaDenmark DenmarkFinland FinlandGermany GermanyNorway NorwaySpain SpainSweden SwedenThe Netherlands The NetherlandsNot Recruiting
A translational RANDOMIZED phase III study exploring the effect of the addition of capecitabine to Carboplatinum based chemotherapy in early “triple negative” breast cancerDenmark DenmarkSweden SwedenNot Recruiting
Adjunctive Pramipexole in Bipolar Depression with Anhedonia: Phase III Double‑Blind Randomized Controlled TrialSweden SwedenNot Yet Recruiting
Alternate-Day Oral Ferrous Sulfate (Duroferon) vs Placebo in Adolescent Girls with Iron Deficiency: A Randomised Double‑Blind Pilot Feasibility StudySweden SwedenNot Yet Recruiting
Comparative Study of Adjuvant Gemcitabine Versus Mitomycin in Intermediate-Risk Non-Muscle Invasive Bladder CancerSweden SwedenNot Recruiting
Contrast Strategy In Fenestrated EndoVascular Aneurysm Repair Randomized Control TrialDenmark DenmarkSweden SwedenNot Yet Recruiting
Effect of orlistat on LIVER fat content in obese subjects with NAFLD and High concEntrAtion of pLasma proneurotensin THrough inhibition of neurotensin secretion and actionSweden SwedenNot Recruiting
Evaluation of Acalabrutinib and Rituximab in Elderly Patients with Untreated Mantle Cell Lymphoma: A Clinical Trial AnalysisDenmark DenmarkFinland FinlandNorway NorwaySweden SwedenNot Recruiting
Evaluation of Aliskiren Versus Enalapril in the Management of C3 Glomerulopathy in Pediatric and Adult PopulationsSweden SwedenNot Recruiting
Evaluation of Diagnostic Accuracy of [18F]RO6958948 and Flutemetamol (18F) in Identifying High-Risk Neurodegenerative Disorders with Tau-PathologySweden SwedenRecruiting
1–10 of 35
1 / 4

Data & Insights

science
Molecule Portfolio
Compounds under investigation
2
Exclusive Molecules
out of 71 total (3% not shared with other sponsors)

This sponsor works with 71 molecules, of which 2 are not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
38%
Return partnership rate
43 of 113 sites collaborated multiple times

This sponsor has worked with 113 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Neoplasms10 trials
    853 other sponsors
  • 2.
    Mental Disorders5 trials
    150 other sponsors
  • 3.
    Bacterial Infections and Mycoses3 trials
    180 other sponsors
  • 4.
    Cardiovascular Diseases3 trials
    359 other sponsors
  • 5.
    Diagnosis3 trials
    83 other sponsors
  • 6.
    Hemic and Lymphatic Diseases3 trials
    249 other sponsors
  • 7.
    Hormonal diseases3 trials
    89 other sponsors
  • 8.
    Immune System Diseases2 trials
    322 other sponsors
  • 9.
    Anesthesia and Analgesia1 trial
    100 other sponsors
  • 10.
    Behavior and Behavior Mechanisms1 trial
    38 other sponsors
  • 11.
    Digestive System Diseases1 trial
    280 other sponsors
  • 12.
    Environment and Public Health1 trial
    7 other sponsors
  • 13.
    Eye Diseases1 trial
    138 other sponsors
  • 14.
    Musculoskeletal Diseases1 trial
    238 other sponsors
  • 15.
    Nervous System Diseases1 trial
    449 other sponsors
  • 16.
    Not possible to specify1 trial
    220 other sponsors
  • 17.
    Nutritional and Metabolic Diseases1 trial
    211 other sponsors
  • 18.
    Otorhinolaryngologic Diseases1 trial
    49 other sponsors
  • 19.
    Pathological Conditions, Signs and Symptoms1 trial
    91 other sponsors
  • 20.
    Psychological Phenomena1 trial
    20 other sponsors
  • 21.
    Respiratory Tract Diseases1 trial
    277 other sponsors
  • 22.
    Skin and Connective Tissue Diseases1 trial
    247 other sponsors
  • 23.
    Virus Diseases1 trial
    182 other sponsors

Partnered Research Centres

113 centres
location_city
assignment335
Aalborg University Hospital
Address
Moelleparkvej 4, 9000 Aalborg
Learn morearrow_forward
location_city
assignment352
Aarhus University Hospital
Address
Palle Juul-Jensens Boulevard 99, 8200 Aarhus
Learn morearrow_forward
location_city
assignment185
Akershus University Hospital
Address
Sykehusveien 25, 1474 Lorenskog
Learn morearrow_forward
location_city
assignment560
Azienda Ospedaliera Universitaria Federico II Di Napoli
Address
Via Sergio Pansini 5, 80131 Naples
Learn morearrow_forward
location_city
assignment214
Azienda Ospedaliero-Universitaria San Luigi Gonzaga
Address
Regione Gonzole 10, 10043 Orbassano
Learn morearrow_forward
location_city
assignment235
Azienda Sanitaria Universitaria Friuli Centrale
Address
Via Pozzuolo 330, 33100 Udine
Learn morearrow_forward
Page 1 of 19

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Region Skane.

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.